Early-Stage Trial Begins for Combined Influenza/COVID-19 Vaccine

Published on September 8, 2021

Vaccine developer Novavax Inc said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine. The trial, to be conducted in Australia, will enroll 640 healthy adults between the ages of 50 and 70 years and who have either been…

Read Full Article (External Site)